Global Endometrial Ablation Market Size to Exceed USD 1.90 Billion by 2033
According to a research report published by Spherical Insights & Consulting, The Global Endometrial Ablation Market Size Expected to Grow from USD 1.08 Billion in 2023 to USD 1.90 Billion by 2033, at a CAGR of 5.81% during the forecast period 2023-2033.
Browse 210 market data Tables and 45 Figures spread through 190 Pages and in-depth TOC on the Global Endometrial Ablation Market Size, Share, and COVID-19 Impact Analysis, By Product (Radiofrequency Ablation and Cryoablation), By End-use (Hospitals and Clinics), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033
The endometrial ablation market is a global industry aimed at devices, technologies, and procedures applied in endometrial ablation, a minimally invasive procedure that seeks to remove or destroy the uterine endometrial lining. It is mainly employed in treating abnormal uterine bleeding (AUB) in non-medication responders who wish not to undergo hysterectomy. Moreover, the endometrial ablation market is reinforced by the growing incidence of abnormal uterine bleeding (AUB), rising demand for less invasive procedures, and evolving ablation technologies. Increasing awareness, increasing healthcare infrastructure, and a desire for cost-effective solutions relative to hysterectomy drive the market further. Changing lifestyles and ageing populations also drive procedure adoption rates higher worldwide. However, the endometrial ablation market is hindered by such challenges as procedure-related complications, restricted use in women who wish to have future pregnancies, device expense, ignorance in developing countries, and availability of alternate modalities such as hormonal therapy.
The radiofrequency ablation segment accounted for the largest share of the global endometrial ablation market in 2023 and is anticipated to grow at a significant CAGR during the forecast period.
On the basis of product, the global endometrial ablation market is divided into radiofrequency ablation and cryoablation. Among these, the radiofrequency ablation segment accounted for the largest share of the global endometrial ablation market in 2023 and is anticipated to grow at a significant CAGR during the forecast period. This is because of its high effectiveness, reduced procedure time, low invasiveness, and quicker recovery. It is also much preferred by healthcare professionals and patients alike compared to cryoablation, which has a longer treatment time and lower rates of adoption.
The hospitals segment accounted for a substantial share of the global endometrial ablation market in 2023 and is anticipated to grow at a rapid pace during the projected period.
On the basis of the end-use, the global endometrial ablation market is divided into hospitals, and clinics. Among these, the hospitals segment accounted for a substantial share of the global endometrial ablation market in 2023 and is anticipated to grow at a rapid pace during the projected period. This is because of its high effectiveness, reduced procedure time, low invasiveness, and quicker recovery. It is also much preferred by healthcare professionals and patients alike compared to cryoablation, which has a longer treatment time and lower rates of adoption.
North America is projected to hold the largest share of the global endometrial ablation market over the projected period.
North America is projected to hold the largest share of the global endometrial ablation market over the projected period. This is attributable to exorbitant healthcare expenditure, sophisticated medical facilities, growing incidence of abnormal uterine bleeding (AUB), and early penetration of minimally invasive technologies. The firm presence of prominent players and rising awareness are additional driving factors fueling regional supremacy over Europe and Asia-Pacific.
Asia Pacific is expected to grow at the fastest CAGR of the global endometrial ablation market during the projected period. This is because of growing investments in healthcare, heightened awareness about minimally invasive procedures, escalating incidence of abnormal uterine bleeding (AUB), and widening access to advanced medical technology. Moreover, a vast population base and better healthcare infrastructure further drive market expansion in the region.
Company Profiling
Major vendors in the global endometrial ablation market are Medtronic, Boston Scientific Corporation, Johnson & Johnson Service Inc., Hologic, Inc., Olympus Corporation, Minerva Surgical, Inc., AngioDynamics, Richard Wolf GmbH, The Cooper Companies, Inc., and others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Recent Development
- In November 2024, Olympus Corporation of the Americas demonstrated its full line of gynecological solutions at the AAGL World Congress. Displayed were hysteroscopy systems with Plasma Hysteroscopic Resection and Vaporization Electrodes, as well as the VERSAPOINT II Bipolar Electrosurgery System. These systems are available for use in procedures like Endometrial ablation.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the global endometrial ablation market based on the below-mentioned segments:
Global Endometrial Ablation Market, By Product
- Radiofrequency Ablation
- Cryoablation
Global Endometrial Ablation Market, By End-Use
Global Endometrial Ablation Market, By Regional
- North America
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa